Holistic Approaches in Substance Use Settings: the ADVANCE-D model as an example of good practice and addressing ender based violence

This is a Research Co-ordinator post with the main responsibility being developing and running seminars and knowledge exchange/research collaboration events, and an annual conference.

The Drugs Research Network Scotland (DRNS) held a webinar on the 5th of May 2026, “The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively…

We offer a variety of innovation programmes to support businesses and researchers in developing and commercialising new products, processes, and services. These programmes can include related funding…

Recording of the webinar in collaboration with the Dr Richard Lowrie from the Centre for Homelessness and Inclusion Health. Reducing overdose and drug deaths in people facing homelessness and other…

Organisations can apply for a share of £20 million across two competitions. Projects will advance development of pharmaceutical, digital and MedTech tools to improve treatment recovery and prevention ...

PhD Project - Trends and characteristics of Opioid, Gabapentinoid and Antidepressant co-prescribing (TOGA) at University of Dundee, listed on FindAPhD.com

Background The unique challenges faced by vulnerable drug users highlight the urgent need for accessible, immediate digital interventions which people can access anywhere and at any time. This study e...

in collaboration with the Centre for Homelessness and Inclusion Health

Subscription and open access journals from Sage, the world's leading independent academic publisher.

A presentation and discussion of research findings on understanding the lethal interaction between benzodiazepines, z-drugs and opioids.

Evaluation findings from the Department for Work and Pensions (DWP) test of Peer Mentoring for individuals with a substance dependency.

A presentation and discussion of research findings on understanding the lethal interaction between benzodiazepines, z-drugs and opioids.

An analysis of women's drug use and gaps in research due to misogynistic policy.